Periscope Capital’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.71M Sell
250,000
-94,000
-27% -$1.01M 0.3% 120
2025
Q4
$3.68M Hold
344,000
0.42% 70
2025
Q3
$3.65M Buy
344,000
+109,000
+46% +$1.15M 0.58% 59
2025
Q2
$2.48M Buy
235,000
+10,000
+4% +$105K 0.55% 56
2025
Q1
$2.32M Hold
225,000
1.01% 37
2024
Q4
$2.28M Sell
225,000
-50,000
-18% -$505K 1.26% 23
2024
Q3
$2.77M Buy
+275,000
New +$2.76M 1.44% 21

Other funds holding GPAT

Periscope Capital's GPAT Position: Q1 2026 in Review

Periscope Capital reduced its GP-Act III Acquisition Corp (GPAT) stake by 27% in Q1 2026, selling an estimated $1.01M and leaving 250,000 shares worth $2.71M. The position accounts for 0.3% of the portfolio, ranked #120.

Periscope Capital first reported a position in GPAT in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.68M in Q4 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Periscope Capital held 250,000 shares of GP-Act III Acquisition Corp worth $2.71M as of Q1 2026.
  • Periscope Capital sold 94,000 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $1.01M.
  • GP-Act III Acquisition Corp made up 0.3% of Periscope Capital's portfolio in Q1 2026, its #120 holding.
  • Periscope Capital first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 7 quarters since.
  • Periscope Capital's GP-Act III Acquisition Corp position peaked at $3.68M in Q4 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Periscope Capital's 13F filing for Q1 2026, filed 14 May 2026.